U.S. Pharmaceuticals & Biotech Undervalued over 20% based on DCF

Eli Lilly

Market Cap: US$985.4b

Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally.

Johnson & Johnson

Market Cap: US$542.4b

Engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide.

AbbVie

Market Cap: US$384.7b

A research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.

Merck

Market Cap: US$293.2b

Operates as a healthcare company worldwide.

Amgen

Market Cap: US$181.8b

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.

Danaher

Market Cap: US$129.3b

Designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally.

Vertex Pharmaceuticals

Market Cap: US$113.6b

Operates as a biotechnology company in the United States, Europe, and internationally.

Teva Pharmaceutical Industries

Market Cap: US$41.1b

Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.

Agilent Technologies

Market Cap: US$38.2b

Provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.

Waters

Market Cap: US$37.7b

Provides analytical workflow solutions in Asia, the Americas, and Europe.

Natera

Market Cap: US$32.0b

A diagnostics company, engages in the development and commercialization of molecular testing services worldwide.

IQVIA Holdings

Market Cap: US$30.4b

Provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific.

Illumina

Market Cap: US$24.7b

Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.

Medpace Holdings

Market Cap: US$12.8b

Provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia.

Elanco Animal Health

Market Cap: US$11.9b

An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.

Revvity

Market Cap: US$11.7b

Provides health sciences solutions, technologies, and services.

ICON

Market Cap: US$10.4b

A clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally.

Qiagen

Market Cap: US$7.6b

Provides sample to insight solutions that transform biological samples into molecular insights worldwide.

Repligen

Market Cap: US$7.0b

A life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally.

Avantor

Market Cap: US$6.2b

Engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.

Ligand Pharmaceuticals

Market Cap: US$4.6b

A biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide.

Sotera Health

Market Cap: US$4.5b

Provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally.

Travere Therapeutics

Market Cap: US$4.4b

A biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States.

Adaptive Biotechnologies

Market Cap: US$2.4b

A commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases.

Maravai LifeSciences Holdings

Market Cap: US$1.2b

A life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin and Central America.

BioLife Solutions

Market Cap: US$1.2b

Develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally.

MannKind

Market Cap: US$1.2b

A biopharmaceutical company, focuses on the provision of various solutions for transforming chronic disease care.

Azenta

Market Cap: US$1.1b

Provides biological and chemical compound sample exploration and management solutions for the life sciences industry in the United States, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally.

Mesa Laboratories

Market Cap: US$563.6m

Develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally.

MiMedx Group

Market Cap: US$548.1m

Develops and distributes placental tissue allografts for various sectors of healthcare.

OmniAb

Market Cap: US$391.4m

A biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan, China, and Canada.

Anika Therapeutics

Market Cap: US$193.3m

A joint preservation company, focuses on early intervention orthopedics in the United States, Europe, and internationally.

AVITA Medical

Market Cap: US$133.3m

Operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.

MindWalk Holdings

Market Cap: US$87.4m

Operates as a bio-native AI company.

Bioqual

Market Cap: US$29.1m

Provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States.

Pharma-Bio Serv

Market Cap: US$12.9m

Operates as a regulatory affair, compliance, and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally.